- Reframe Daily
- Posts
- Reframe Daily: blood test beats biopsies, combo inhaler, faster stroke care, walking meditation benefits
Reframe Daily: blood test beats biopsies, combo inhaler, faster stroke care, walking meditation benefits
From a painless blood draw and a smarter asthma inhaler to a faster stroke rescue, longer breast-cancer survival, and fresh hope for a rare disease, here’s the quick rundown.
Christin Chong, PhD
July 10, 2025
Reframe Daily is where Christin Chong (neuroscience PhD, chaplain, healthtech strategy consultant) curates optimistic and credible healthtech news so you don’t have to. Save 40 hours of reading with this issue!
Today in one sentence: Doctors found a way to spot bone-marrow stem cells with only a blood test, a single rescue inhaler cut mild-asthma attacks, an old heart-attack drug given early helped stroke patients, a new pill let women with hard-to-treat breast cancer live longer, and scientists mapped a multi-step plan to fix a rare energy-draining illness.
Christin’s note: Oops, turns out many of you had not received Reframe Daily because of some DNS errors on my end! In the missing issue, I mentioned being back from a bunch of hiking/walking in the wilderness and inspired to share this Buddhist sutta (scripture) about walking meditation:
Mendicants, there are these five benefits of walking up & down. What five?
One is fit for long journeys; one is fit for striving; one has little disease; that which is eaten, drunk, chewed, tasted, goes through proper digestion; the composure attained by walking up & down is long-lasting.
These, mendicants, are the five benefits of walking up & down.
Good news: Scientists found a safe way to spot our bone-marrow stem cells with just a simple blood draw, which could someday replace painful biopsies and help doctors catch blood diseases earlier.
Market readiness: 🙂 (Early lab discovery—no human testing yet)
Good news: Kids and adults with mild asthma had fewer scary attacks when they used one combo inhaler (albuterol + budesonide) only when they felt symptoms, meaning just one device in the pocket can keep them safer.
Market readiness: 🙂🙂🙂🙂🙂 (Medicine already FDA-approved and on pharmacy shelves)
Good news: Giving stroke patients a single IV dose of tenecteplase before clot-removal surgery helped open blocked arteries faster, pointing to better chances of walking away without disability.
Market readiness: 🙂🙂🙂🙂 (Drug is already approved for heart attacks; stroke use now backed by Phase 3 data and could enter guidelines soon)
Good news: A new pill called inavolisib helped women with hard-to-treat, PIK3CA-mutated breast cancer live longer in a large study, offering new hope when other treatments stop working.
Market readiness: 🙂🙂🙂 (Successful Phase 3 trial—company likely to file with FDA next)
Good news: Researchers showed that treating a rare, energy-draining disease caused by CoQ10 problems needs a combo approach, pointing the way to better therapies that could give patients more strength and longer lives.
Market readiness: 🙂 (Bench and animal work—human trials still ahead)
That’s all folks, thank you for reframing the way you think.